Prosanto Kumar Chowdhury

This study identifies six molecular pathways associated with thalassemia severity in patients with identical mutations, highlighting non-genetic factors contributing to disease outcomes.

The paper investigates how alpha globin gene deletions affect clinical severity in beta-thalassemia patients with specific genotypes, finding significant amelioration in the β+/β0 genotype.

The paper introduces a severity scoring system for beta-haemoglobinopathies using clinical parameters to classify patients as severe or non-severe, achieving 94% accuracy in a cohort of Eastern Indian patients.